Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1428-1435

  Mitsudo, Kenji ^a   Shigetomi, Toshio ^b   Fujimoto, Yasushi ^b   Nishiguchi, Hiroaki ^b   Yamamoto, Noriyuki ^b   Furue, Hiroki ^b   Ueda, Minoru ^b   Itoh, Yoshiyuki ^b   Fuwa, Nobukazu ^c   Tohnai, Iwai ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Southern Tohoku General Hospital   (Japan)

Author keywords

Chemoradiotherapy; Head and neck cancer; Organ preservation; Superselective intra arterial infusion; Survival rate

Indexed keywords

ARTERIAL INFUSION; CHEMORADIOTHERAPY; HEAD AND NECK CANCER; ORGAN PRESERVATION; SURVIVAL RATE;

CHEMOTHERAPY; PLATINUM COMPOUNDS; RADIOTHERAPY;

DISEASES;

CISPLATIN; DOCETAXEL; SODIUM THIOSULFATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DERMATITIS; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; JAW OSTEONECROSIS; MALE; MANDIBLE; MAXILLA; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUPERFICIAL TEMPORAL ARTERY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; TAXOIDS; TEMPORAL ARTERIES; TREATMENT OUTCOME;

EID: 79952703712     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.011     Document Type: Article

References (27)

1. Lee YY, Wallace S, Dimery I, et al. Intraarterial chemotherapy of head and neck tumors. AJNR 1986;7:343-348. (Pubitemid 16153107)
2. Robbins KT, Storniolo AM, Kerber C, et al. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364-371.
3. Robbins KT, Vicario D, Seagren S, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. Am J Surg 1994;168:419-422. (Pubitemid 24345687)
4. Hattori T, Hirano T, Toyoda S, et al. Superselective continuous intra-arterial infusion therapy via superficial temporary artery for head and neck tumors. Jpn J Radiat 1985;45:1056-1058.
5. Fuwa N, Ito Y, Kato E, et al. Superselective intra-arterial continuous chemotherapy with CBDCA for advanced head and neck cancer. Jpn J Head Neck Cancer 1996;22:139-143.
6. Tohnai I, Fuwa N, Hayashi Y, et al. New superselective intraarterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 1998;34:387-390. (Pubitemid 28440302)
7. Tohnai I, Fuwa N, Mitsudo K, et al. Daily concurrent preoperative chemoradiotherapy with docetaxel (D) and cisplatin (C) using new superselective intra-arterial infusion via superficial temporal artery (HFT method) for stage III, IV head and neck cancer, abstract 5567. In: Steven M. Grunberg, editor. Proceedings of the 41st American Society for Clinical Oncology Annual Meeting. Orland, FL; 2005; 516.
8. Eastern Cooperative Oncology Group. ECOG Performance Status. Available at: http://ecog.dfci.harvard.edu/general/perf-stat.html. Last accessed May 13, 2010.
9. Sobbin LH, Wittekind C, eds. TMN classification of malignant tumors. International Union Against Cancer. New York: Wiley-Liss; 2002.
10. Tohnai I. Chemotherapy using intra-arterial infusion for oral cancer. Nagoya J Med Sci 2006;68:101-108.
11. Fuwa N, Kodaira T, Furutani K, et al. A new method of selective intra-arterial infusion therapy via the superficial temporal artery for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:783-789.
12. National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0 .Available at: http://ctep.cancer.gov/protocolDevelopment/ electronic-applications/docs/ctcaev3.pdf. Last accessed May 13, 2010.
13. Fuwa N, Ito Y, Matsumoto A, et al. A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Cancer 2000;89:2099-2105.
14. Gemmete JJ. Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. J Vasc Interv Radiol 2003;14:743-748. (Pubitemid 36718108)
15. Homma A, Furuta Y, Suzuki F, et al. Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer. Head Neck 2005;27:65-71. (Pubitemid 40024091)
16. Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: Results of radiation therapy oncology group trial 9615. J Clin Oncol 2005;23:1447-1454.
17. Balm AJM, Rasch CRN, Schornagel JH, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 2004;26:485-493. (Pubitemid 38702635)
18. Inohara H, Inoue T, Akahani S, et al. Concurrent chemoradiotherapy with cisplatin and docetaxel for advanced head and neck cancer. A phase I study. Anticancer Res 2004;24:4135-4140. (Pubitemid 40468719)
19. Hill BT, Whelan DH, Shellard SA, et al. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro. Invest New Drugs 1994;12:169-182. (Pubitemid 24376401)
20. Maeda S, Sugiura T, Saikawa Y, et al. Docetaxel enhances the cytotoxicity of cisplatin to gastric cells by modification of intracellular platinum metabolism. Cancer Sci 2004;95:679-684.
21. Tohnai I, Mitsudo K, Shigetomi T, et al. Daily concurrent preoperative chemoradiotherapy using new superselective intraarterial infusion via superficial temporal artery for stage III, IV head and neck cancer - Cisplatin versus docetaxel plus cisplatin, abstract 2036. In: Steven M. Grunberg, editor. Proceedings of the 39th American Society for Clinical Oncology Annual Meeting, Chicago IL; 2003;506.
22. Hanna E, Alexiou M, Morgan J, et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: Efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 2004;130:861-867. (Pubitemid 38915974)
23. Studer G, Zwahlen RA, Graetz KW, et al. IMRT in oral cavity cancer. Radiat Oncol 2007;2:16.
24. Wahl MJ. Osteoradionecrosis prevention myths. Int J Radiat Oncol Biol Phys 2006;3:661-669. (Pubitemid 43183558)
25. Eisbruch AE, Harris J, Garden AS, et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 2010;76:1333-1338.
26. Ben-David MA, Diamante M, Radawski JD, et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys 2007;1:396-402. (Pubitemid 46694162)
27. Mitsudo K, Tohnai I, Fujimoto Y, et al. Leiomyosarcoma of maxilla: Effective chemotherapy with docetaxel (DOC) and cisplatin (CDDP) using superselective intra-arterial infusion via superficial temporal artery. Oral Oncol Extra 2006;42:258-262. (Pubitemid 44189956)